June 22, 2026 Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 – the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis
June 22, 2026 NetworkNews Audio Announces Audio Press Release (APR) Discussing AI Infrastructure Demand Creating Urgent Need for Scalable, Intelligent Automation
June 22, 2026 Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
June 22, 2026 NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
